Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A clinician's guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer.
Veen KM, de Angst IB, Mokhles MM, Westgeest HM, Kuppen M, Groot CAU, Gerritsen WR, Kil PJM, Takkenberg JJM. Veen KM, et al. Among authors: groot cau. J Cancer Res Clin Oncol. 2020 Aug;146(8):2067-2075. doi: 10.1007/s00432-020-03286-8. Epub 2020 Jun 17. J Cancer Res Clin Oncol. 2020. PMID: 32556680 Free PMC article. Review.
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
Holleman MS, Huygens SA, Al MJ, Kuppen MCP, Westgeest HM, van den Bergh ACM, Bergman AM, van den Eertwegh AJM, Hendriks MP, Lampe MI, Mehra N, van Moorselaar RJA, van Oort IM, Somford DM, de Wit R, van de Wouw AJ, Gerritsen WR, Groot CAU. Holleman MS, et al. Among authors: groot cau. Drugs Real World Outcomes. 2022 Jun;9(2):275-285. doi: 10.1007/s40801-022-00294-7. Epub 2022 Mar 21. Drugs Real World Outcomes. 2022. PMID: 35314962 Free PMC article.
High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients: Results from the Dutch CAPRI-Registry.
Westgeest HM, Kuppen MCP, van den Eertwegh FAJM, van Oort IM, Coenen JLLM, van Moorselaar JRJA, Aben KKH, Bergman AM, Huinink DTB, van den Bosch J, Hendriks MP, Lampe MI, Lavalaye J, Mehra N, Smilde TJ, Somford RDM, Tick L, Weijl NI, van de Wouw YAJ, Gerritsen WR, Groot CAU. Westgeest HM, et al. Among authors: groot cau. J Palliat Med. 2021 Dec;24(12):1789-1797. doi: 10.1089/jpm.2020.0800. Epub 2021 Aug 19. J Palliat Med. 2021. PMID: 34415798
Fair Pricing of Innovative Medicines: An EHA Position Paper.
Hagenbeek A, Gribben J, Jäger U, Kapitein P, Merlini G, Piggin M, Groot CAU, Doeswijk R. Hagenbeek A, et al. Among authors: groot cau. Hemasphere. 2020 Sep 30;4(5):e488. doi: 10.1097/HS9.0000000000000488. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33134863 Free PMC article. No abstract available.
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.
Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Tascilar M, Mehra N, Lavalaye J, Somford DM, Aben KKH, Bergman AM, de Wit R, van den Bergh ACMF, de Groot CAU, Gerritsen WR. Kuppen MCP, et al. Among authors: de groot cau. Clin Genitourin Cancer. 2022 Feb;20(1):43-52. doi: 10.1016/j.clgc.2021.10.008. Epub 2021 Nov 2. Clin Genitourin Cancer. 2022. PMID: 34848157 Free article.
11 results